Vivo Capital, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$2.2T
Holdings
60
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (60 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX Oncology Holdings Inc | 4,220,048 | $311.7B | 14.00% | |
| 2 | TILInstil Bio Inc | 12,486,787 | $223.2B | 10.02% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 4,884,341 | $187.2B | 8.41% | |
| 4 | —New Frontier Health Corp | 14,300,000 | $160.6B | 7.21% | |
| 5 | AMRSEURAmyris, Inc | 11,642,195 | $159.8B | 7.18% | |
| 6 | ASNDAscendis Pharma A/S | 760,606 | $121.2B | 5.44% | |
| 7 | OPHTEURIveric Bio Inc | 5,966,527 | $96.9B | 4.35% | |
| 8 | —Genetron Holdings Ltd | 6,339,860 | $87.8B | 3.94% | |
| 9 | TARSTarsus Pharmaceuticals Inc | 2,987,331 | $64.4B | 2.89% | |
| 10 | ALGSAligos Therapeutics Inc | 3,547,030 | $55.0B | 2.47% | |
| 11 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $49.0B | 2.20% | |
| 12 | —Sierra Oncology, Inc | 1,917,074 | $42.0B | 1.89% | |
| 13 | WHWKAadi Bioscience Inc | 1,427,213 | $41.9B | 1.88% | |
| 14 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 1.71% | |
| 15 | —Kadmon Holdings Inc | 4,283,014 | $37.3B | 1.68% | |
| 16 | —Impel NeuroPharma Inc | 2,884,789 | $35.1B | 1.58% | |
| 17 | OLMAOlema Pharmaceuticals Inc | 1,238,575 | $34.1B | 1.53% | |
| 18 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $28.8B | 1.29% | |
| 19 | KALVKalVista Pharmaceuticals Inc. | 1,641,913 | $28.7B | 1.29% | |
| 20 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $27.9B | 1.25% | |
| 21 | TCE2Celldex Therapeutics Inc | 484,453 | $26.2B | 1.17% | |
| 22 | LEGNLegend Biotech Corp Sponsored | 488,751 | $24.7B | 1.11% | |
| 23 | VRDNViridian Therapeutics Inc | 1,300,000 | $21.4B | 0.96% | |
| 24 | SERASera Prognostics Inc | 1,856,011 | $20.6B | 0.93% | |
| 25 | ZLABZai Lab Ltd ADR | 174,999 | $18.4B | 0.83% | |
| 26 | ACRSAclaris Therapeutics, Inc. | 940,754 | $16.9B | 0.76% | |
| 27 | MREOMereo Biopharma Group PLC | 6,907,189 | $16.7B | 0.75% | |
| 28 | VRNAVerona Pharma PLC | 2,749,918 | $15.1B | 0.68% | |
| 29 | NKTXNkarta Inc | 512,225 | $14.2B | 0.64% | |
| 30 | —Dice Therapeutics Inc | 410,000 | $13.4B | 0.60% | |
| 31 | GRCLGracell Biotechnologies Inc | 961,359 | $13.3B | 0.60% | |
| 32 | —Curis Inc | 1,553,500 | $12.2B | 0.55% | |
| 33 | COGTCogent Biosciences Inc | 1,420,941 | $11.9B | 0.54% | |
| 34 | 290AChinook Therapeutics Inc | 872,151 | $11.1B | 0.50% | |
| 35 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $11.1B | 0.50% | |
| 36 | CRNXCrinetics Pharmaceuticals Inc | 517,280 | $10.9B | 0.49% | |
| 37 | ARQTArcutis Biotherapeutics Inc | 433,585 | $10.4B | 0.47% | |
| 38 | KURAKura Oncology Inc | 525,262 | $9.8B | 0.44% | |
| 39 | MRUSMerus NV | 442,000 | $9.7B | 0.44% | |
| 40 | DYNDyne Therapeutics Inc | 577,642 | $9.4B | 0.42% | |
| 41 | CDXSCodexis, Inc | 388,144 | $9.0B | 0.41% | |
| 42 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $8.6B | 0.39% | |
| 43 | EPIEUREssa Pharma Inc | 1,056,067 | $8.4B | 0.38% | |
| 44 | —Zymeworks Inc | 286,064 | $8.3B | 0.37% | |
| 45 | DSGNDesign Therapeutics | 530,991 | $7.8B | 0.35% | |
| 46 | FIXXEURHomology Medicines, Inc. | 853,143 | $6.7B | 0.30% | |
| 47 | VALNValneva SE | 200,000 | $6.3B | 0.28% | |
| 48 | SNDXSyndax Pharmaceuticals Inc | 320,000 | $6.1B | 0.27% | |
| 49 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $5.7B | 0.26% | |
| 50 | PASGPassage Bio Inc | 539,263 | $5.4B | 0.24% | |
| 51 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $5.1B | 0.23% | |
| 52 | LRMRLarimar Therapeutics Inc | 399,830 | $4.6B | 0.21% | |
| 53 | —Elevation Oncology Inc | 496,843 | $3.9B | 0.17% | |
| 54 | CLDNEUREiger BioPharmaceuticals Inc | 469,588 | $3.1B | 0.14% | |
| 55 | ORTXUSDOrchard Therapeutics plc | 1,325,736 | $3.0B | 0.14% | |
| 56 | TXG10X Genomics Inc | 14,798 | $2.2B | 0.10% | |
| 57 | DTILPrecision Biosciences Inc | 140,255 | $1.6B | 0.07% | |
| 58 | —Zogenix Inc | 105,000 | $1.6B | 0.07% | |
| 59 | 1T7Tricida, Inc. | 167,863 | $779.0M | 0.03% | |
| 60 | —Metacrine Inc | 146,426 | $502.0M | 0.02% |